Voluntary 'pause' in controversial H5N1 virus research lauded
This article was originally published in Scrip
A month after the US government asked scientists to hold off publishing the details of their research describing a genetically-modified form of the H5N1 avian flu virus, which has been found to be highly transmissible in ferrets, over worries terrorists could use the information for harmful purposes, the researchers agreed to voluntarily "pause" their work for 60 days (scripintelligence, 21 December 2011).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.